TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NTRA

Natera Inc

Healthcare · Diagnostics & Research

369.40$ +0.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement NTRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+19.5% +14.0% -2.8% +22.1% +17.3% +29.3% +60.0% +31.1% +32.0% +56.7% +35.9%
+43.9% +20.1% +3.0% +19.0% +5.7% +16.0% +56.4% +43.3% +29.3% +14.2% +20.3%
-4.2% +5.1% -12.5% +28.4% +38.5% +47.7% +63.9% +18.5% +35.4% +107.6% +46.2%
+60.3% +51.1% +19.6% +2.6% +0.0% +94.8% +164.1% +19.8% +1.3% +26.0% +54.4%
+77.3% +24.2% +14.1% -0.3% +33.1% +47.3% +68.3% +15.2% +5.0% +36.1% +39.9%
+71.2% +29.6% +15.4% +0.4% +17.9% +66.0% +92.1% +16.7% +3.8% +32.6% +45.0%
-9,098.2%
-16.9% -84.8% +690.4% +148.7% +2.1% +41.0% -44.9% +12.2% +35.6% -15.5% -61.9%
-496.6% +219.7% -29.3% +522.7% -95.1% +530.6% +58.3% -72.3% +156.5% -8,722.9%
-1,552.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?